Friday, August 18, 2017 6:08:07 PM
If Nantcell is in on it they are foolish,
If anything, since the product/s is/are real and the global license deal is evident both companies should merge an a profitable agreement reached without share splits.
Paper holds every word you put on it,
An RS is like cheating, the company will not be trusted again.
RS "NO"
6 month daily chart, forth run of the year coming up. Hold your shares.
http://www.fiercebiotech.com/biotech/soon-shiong-s-nantcell-356m-deal-for-underperforming-cytrx-cancer-drug
Mr Soon is beru smart and has a ton of money, they will be loading up next week,
This is a strategic plan to acquire cheap shares.
Wise
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM